<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39450094</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Universal versus targeted coronavirus disease 2019 (COVID-19) arrival antigen testing on subsequent COVID-19 infections in military trainees.</ArticleTitle><Pagination><StartPage>e182</StartPage><MedlinePgn>e182</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e182</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.365</ELocationID><Abstract><AbstractText>In this retrospective cohort study of military trainees, symptomatic-only coronavirus disease 2019 (COVID-19) arrival antigen testing decreased isolation requirements without increasing secondary cases compared to universal antigen testing. Symptomatic-only arrival antigen testing is a feasible alternative for individuals entering a congregant setting with a high risk of COVID-19 transmission.</AbstractText><CopyrightInformation>© Cambridge University Press 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Westbrook</LastName><ForeName>Marquise D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0009-0005-5945-7472</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Service, Department of Medicine, Brook Army Medical Center, JBSA-Fort Sam Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aden</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9365-4983</Identifier><AffiliationInfo><Affiliation>Biostatistics Department, San Antonio Uniformed Services Health Education Consortium, JBSA-Fort Sam Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kieffer</LastName><ForeName>John W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-1790-1476</Identifier><AffiliationInfo><Affiliation>Trainee Health Surveillance, 559 Medical Group, JBSA-Lackland, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Erin L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Trainee Health Surveillance, 559 Medical Group, JBSA-Lackland, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osuna</LastName><ForeName>Angela B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Trainee Health Surveillance, 559 Medical Group, JBSA-Lackland, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Theresa M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Trainee Health Surveillance, 559 Medical Group, JBSA-Lackland, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frankel</LastName><ForeName>Dianne N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>USAFRICOM HQ, Office of the Command Surgeon, Stuttgart, GE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiley</LastName><ForeName>John L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-1726-1699</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Service, Department of Medicine, Brook Army Medical Center, JBSA-Fort Sam Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Heather C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Infectious Diseases Service, Department of Medicine, Brook Army Medical Center, JBSA-Fort Sam Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcus</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-1789-603X</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Service, Department of Medicine, Brook Army Medical Center, JBSA-Fort Sam Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39450094</ArticleId><ArticleId IdType="pmc">PMC11500260</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.365</ArticleId><ArticleId IdType="pii">S2732494X24003656</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hayden MK, Hanson KE, Englund JA, et al. The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing (January 2023). Clin Infect Dis 2024;78:e350–e384.</Citation><ArticleIdList><ArticleId IdType="pubmed">36702617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cybulski DJ, Matthews Z, Kieffer JW, et al. Impact of SARS-CoV-2 arrival surveillance screening by nucleic acid amplification versus rapid antigen detection on subsequent COVID-19 infections in military trainees. Clin Infect Dis 2023;78:65–69.</Citation><ArticleIdList><ArticleId IdType="pubmed">37610361</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus JE, Frankel DN, Pawlak MT, et al. Risk factors associated with COVID-19 transmission among US Air Force trainees in a congregant setting. JAMA Network Open 2021;4:e210202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907953</ArticleId><ArticleId IdType="pubmed">33630090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrou AS, Shirk P, Steele MK, Paul P, Paden CR, Cadwell B, et al. Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants - United States, June 2021–January 2022. MMWR 2022;71:206–211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8830620</ArticleId><ArticleId IdType="pubmed">35143464</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews ZK, Cybulski DJ, Frankel DN, Kieffer JW, Casey TM, Osuna AB, et al. Sensitivity of Symptom-Based Screening for COVID-19 in Active Duty Basic Trainees. Military medicine. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37192055</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor CA, Patel K, Pham H, Whitaker M, Anglin O, Kambhampati AK, et al. Severity of disease among adults hospitalized with laboratory-confirmed COVID-19 before and during the period of SARS-CoV-2 B.1.617.2 (Delta) predominance - COVID-NET, 14 states, January–August 2021. MMWR 2021;70:1513–1519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553023</ArticleId><ArticleId IdType="pubmed">34710076</ArticleId></ArticleIdList></Reference><Reference><Citation>Frediani JK, Parsons R, McLendon KB, Westbrook AL, Lam W, Martin G, et al. The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs. medRxiv : the preprint server for health sciences. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10874267</ArticleId><ArticleId IdType="pubmed">37768707</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>